Ridaura

Ridaura is a brand name of auranofin, approved by the FDA in the following formulation(s):

RIDAURA (auranofin - capsule; oral)

• 
  Manufacturer: PROMETHEUS LABS
  
  Approval date: May 24, 1985
  
  Strength(s): 3MG ^[RLD]

Has a generic version of Ridaura been approved?

No. There is currently no therapeutically equivalent version of Ridaura available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ridaura. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Ridaura.

See also...

• Ridaura Consumer Information (Wolters Kluwer)
• Ridaura Consumer Information (Cerner Multum)
• Auranofin Consumer Information (Wolters Kluwer)
• Auranofin Consumer Information (Cerner Multum)